socalTECH

JUNE 30, 2010

San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. TargeGen had raised over $113M in venture funding from A.M. The firm was advised by Peter J.

Enterprise Partners 140

Enterprise Partners San Diego Acquisition Pricing 140

socalTECH

JULY 10, 2009

San Diego-based Scoperta , which is developing fabless specialty steel technology utilizing scrap materials, has raised $1.4M Other details on the funding have not been released, however, the firm is backed by Enterprise Partners and Vista Ventures, and Drew Senyei of Enterprise sits on the firm's board of directors.

Enterprise Partners 100

Enterprise Partners San Diego Capital Technology 100

socalTECH

OCTOBER 1, 2009

The information--gleaned from funding announcements, regulatory filings, and other sources--are not far off from socalTECH's totals from last quarter, which totaled up around $932M in investment activity. San Diego led investment activity in Q3, with a large number of the biggest VC deals all located in the area.

Southern California 140

Southern California Venture Capital Northridge Tech Coast Angels 140

socalTECH

JANUARY 12, 2015

In our interviews, we normally talk to entrepreneurs, investors, and others involved in the technology startup industry. I talked to my partners, who were very supportive, and since then have been off to the races. What are the biggest difference between technology startups and running a restaurant franchise?

Startup 100

Startup Anthem Venture Capital Technology 100